Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the Pitfall

Anna Margherita Maffione; Luca Urso; Modonesi Caterina; Sotirios Chondrogiannis; Gaia Grassetto; Paola Bartoletti; Maria Cristina Marzola

doi:10.4103/ijnm.ijnm_65_23

Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the Pitfall

Indian J Nucl Med. 2023 Oct-Dec;38(4):402-403. doi: 10.4103/ijnm.ijnm_65_23. Epub 2023 Dec 20.

Authors

Anna Margherita Maffione¹, Luca Urso¹, Modonesi Caterina², Sotirios Chondrogiannis¹, Gaia Grassetto¹, Paola Bartoletti¹, Maria Cristina Marzola¹

Affiliations

¹ Department of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
² Oncology Unit, AULSS6 Euganea, Ospedali Riuniti Padova Sud, Monselice, PD, Italy.

Abstract

We report a case of a patient performing a positron emission tomography-computed tomography (PET-CT) scan with [18F]F-Choline for biochemical relapse (Prostate specific antigen (PSA) 1.2 ng/ml) of prostate cancer. Two large areas of focal uptake with a cold core within the liver were observed. A contrast-enhanced ultrasound scan performed after the PET scan characterized these lesions as cavernous hepatic hemangiomas, and therefore, a biopsy was not performed; 3 years of follow-up and PET and MRI finding stability confirmed the benignity of their nature.

Keywords: 18F-choline positron emission tomography–computed tomography; cavernous hepatic hemangiomas; contrast-enhanced ultrasound; hepatocellular carcinoma; positron emission tomography–computed tomography; prostate cancer.